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Schistosomal specific nephropathy leading to end—stage renal failure. In
this study 17 patients, 11 with end—stage renal failure and six with
nephrotic syndrome were selected. The selection criteria were presence
of active intestinal schistosomiasis and absence of any surgical or other
medical disease which could explain the renal disease. When examined
by light microscopy, kidney biopsies showed membranoproliferative
glomerulonephritis in nine, membranous in four, focal segmental gb-
merulosclerosis in two, sclerosing glomerulonephritis in one case, and
no changes in another case. Direct immunofluorescence showed IgG
deposits in 13 cases, 1gM in 10 and different complement components
(C3, Clq) in eight cases. Eluates from the kidney biopsies of the 17
schistosomal as well as six control cases were examined by ELISA
against schistosoma mansoni adult worm antigen (AWA). This test
showed the presence of antibodies against the AWA in 12 out of 17 of
the schistosomal cases, and zero out of six of the controls. When
examined by direct IFA using sheep anti-circulating anodic antigen!
FITC and by indirect IFA using monoclonal antischistosomal CAA
IgG3, kidney biopsies of the ELISA positive cases showed granular
deposits of circulating anodic antigen (CAA). We conclude that
schistosomal specific nephropathy does exist in the clinical settings and
can lead to end—stage renal disease, with CAA probably being a major
responsible antigen,
Schistosomiasis is a chronic helminthic disease of man and
animal which in the absence of reinfestation may persist for 10
to 12 years, or in exceptional cases up to 30 years. Since a wide
variety of viral, bacterial and parasitic diseases which chroni-
cally stimulate the host have been shown to induce glomerulo-
nephritis [1, 21, similar renal damage might be expected to
develop with schistosomal infestation.
Andrade, Andrade and Sadigursky [3] had reported that 12 to
15% of patients with hepatosplenic schistosomiasis have gb-
merulonephritis. The majority of such patients show a diffuse
membranoproliferative glomerulonephritis [4—6]. Unfortunate-
ly, without demonstration of schistosomal specific antigen
deposited in the glomeruli, the possibility of a coincidental
finding such as membranoproliferative glomerulonephritis of
other etiologies in a bilharzial patient cannot be ruled out.
The presence of schistosomal specific nephropathy was in-
vestigated in some of our cases presenting with an end—stage
renal pathology, and the possible presence of a specific schisto-
some antigen in renal biopsies was investigated.
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Methods
Seventeen patients with parenchymal renal disease were the
subject of this study. The selection criteria were the presence of
active schistosoma mansoni infestation (which was diagnosed
by finding of schistosoma eggs in the stool and/or in a rectal
mucosal biopsy) and the absence of any other disease which
could explain their renal pathology such as systemic lupus,
recurrent throat infection or pyelonephritis. All these patients
had hepatosplenomegaly. In addition six non-schistosomal pa-
tient served as controls. Sufficient kidney biopsy tissue was
obtained by a percutaneous needle technique or by an open one
through a small lumbotomy incision. In addition, normal kidney
tissue was obtained from the lower pole of a nephrectomized
kidney which had been removed due to an upper pole tumour.
Processing of the kidney biopsies
Two cores of tissues were obtained. The first was preserved
in 10% formalin, from which paraffin sections were prepared
and stained by hematoxylin and eosin, masson trichrome,
periodic acid schiff (PAS), periodic acid silver methenamin
(PASM) and Congo—red stains. The second core was immedi-
ately frozen and stored at —70°C. Frozen sections were proc-
essed as follows.
Direct immunofluorescence for different immuno globulins
and complement components deposits. Sections were stained
by fluorescein—labeled anti-human IgG, 1gM, IgA, C3, C4, Clq
and fibrinogen.
Tissue eluates were tested for the existence of schistosomal
spec jfic antibodies by means of an enzyme—linked immunosor-
bent assay (ELISA) using saline extract of lyophilized adult,
schistosoma—mansoni worm antigen. Biopsy specimens were
sectioned to 4 to 5 s with a rotatory microtome in a cryostat at
—25°C. In order to obtain a sufficient eluate these sections were
placed in wells of multiwell cell culture plates (Flow Lab,
Scotland, UK). Renal sections in the well were incubated
overnight with 0.25 ml of 0.02 M citrate buffer, pH 3.2, at 4°C.
The citrate buffer, now referred to as the eluate, was transferred
to a small tube, and then neutralized by addition of 0.2 M
sodium hydroxide. The total protein content in the eluate was
determined by the method of Lowry et al [71, and its fractions
were identified by celbogel electrophoresis and immunoelectro-
phoresis, which was carried out on microscope slides covered
with an agarose gel (1% wtlvol agarose pure in veronal buffer,
pH 8.2). One hundred pi 20 x concentrated eluates were used.
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Table 1. Evaluation of schistosomal and control groups
Case
Schisto-
somiasis Age Sex
Clinical
status
Biopsy
findings
Antibody
(ELISA)
FITC
anti-CAA Remarks
1 + 38 M CRF MCGN + + On dialysis
2 + 42 M CRF MGN + + On dialysis
3 + 36 M CRF MCGN + + On dialysis
4 + 37 M CRF Sclerosing — — On dialysis
5 + 22 F CRF MCGN + + On dialysis
6 + 24 M CRF MGN — — On dialysis
7 + 18 M CRF MCGN — — On dialysis
8 + 18 F CRF MCGN + + On dialysis
9 + 24 M CRF MCGN + + On dialysis
10 + 26 M CRF MCGN — — On dialysis
11 + 20 F CRF MGN + + On dialysis
12 + 25 M Nephrotic MCGN + + Renal impairmemt
13 + 14 M Nephrotic MCGN + + Renal impairment
14 + 20 M Nephrotic MGN — — Renal impairment
15 + 22 M Nephrotic No change + + Normal kidney function
16 + 18 M Nephrotic FSGS + + Normal kidney function
17 + 18 M Nephrotic FSGS + + Normal kidney function
18 — 18 M CRF MCGN — — On dialysis
19 — 18 M CRF MCGN — — On dialysis
20 — 18 M CRF MON — — On dialysis
21 — 22 F CRF MCGN — — On dialysis
22 — 18 M Nephrotic FSGS — — Normal kidney function
23 — 20 M Nephrotic MGN — — Normal kidney function
24 — 36 M Hypernephroma Normal — — Normal kidney function
Electrophoresis was carried out for three hours at 55 V and 3.5
mmp per slide.
Adult worm antigen (AWA) was prepared by homogenization
of worms which had been washed three times with Dulbeccos
balanced salt—solution in a glass homogenizer at 4°C. The
homogenate was centrifuged for 30 minutes at 25,000 x g (4°C),
and was then dialyzed against distilled water (24 hours, 4°C). It
was then lyophilized. The protein content of AWA was deter-
mined by the Lowry method, using bovine serum albumin as a
standard. Each gram of AWA contained 0.36 grams of protein,
that is, protein content was 36%.
To test the eluates for antibodies against schistosome anti-
gens an indirect ELISA was employed. Flat—bottom wells in
polystyrene microtiter plates (Flow Lab) were each coated with
100 pi of 10 J.Lg/ml schistosome antigen dissolved in 0.1 M
sodium carbonate buffer, pH 9.6. The plates were incubated
overnight at room temperature, and then washed three times
with 0.01 M phosphate buffer saline (PBS), pH 7.2. A 150 d of
5% bovine serum albumin (BSA) dissolved in PBS was added to
each well and the plates were incubated for 60 minutes at 37°C.
The plates were then washed three times with PBS containing
0.05% Tween 20. A 95 l of patient and control eluates, at
constant protein content (300 /.LgIml) diluted in PBS-Tween
containing 5% BSA for patient and control eluates, were added
to each well. The plate was washed again three times after
incubation for 120 minutes at 37°C. A 90 pi of an optimal
dilution of anti-human polyvalent immunoglobulins peroxi-
dase—conjugate (Sigma Chemical Co., St. Louis, Missouri,
USA) in PBS-Tween-BSA were added to all wells, and the
plants were incubated overnight at room temperature in humid
conditions. Following three washings, 100 d of substrate
solution (orthophenylenediamine) were added to the wells and
allowed to react for 30 minutes at room temperature. The
enzyme reaction was stopped by addition of 25d of 1 N HCI.
Optical densities (OD) were measured at 492 nm using an
8-channel photometer, (Titertek Multiskan, Flow Lab).
A blocking test was performed on ELISA positive eluates to
ensure specificity. A 100 d portion of each eluate (in equal
protein concentration, 300 pglml) was added to a 100 pi of
schistosoma antigen (400 tg/ml) and allowed to incubate for
two hours at 37°C followed by an overnight incubation at 4°C.
Uninhibited eluates were also included in the test. Both inhib-
ited and uninhibited eluates were tested by ELISA as explained
above and the percentage inhibition was calculated by using the
following formula.
'OD in presence of inhibitor
Percent inhibition = 100- I
\OD in absence of inhibitor 100)
The renal biopsy samples were further stained by direct
immunofluorescence using FITC-conjugated, anti-circulating
anodic antigen (anti-CAA). This antiserum was prepared by
immunization of sheep against CAA according to the method of
Deelder, Van Dalen and Van Egmond [81. The antiserum was
tested with immunoelectrophoresis against CAA, and the IgG
fraction was isolated using the caprylic acid—precipitation tech-
nique. FITC conjugate was then prepared. Direct im-
munofluorescence tests were performed according to the stan-
dard procedure on air—dried, acetone—fixed cryostate sections,
using conjugate dilutions of '/8 to ¼o. Sections were examined
by a Leitz (Leitz Inc., Heerbrugg, Switzerland) fluorescent
microscope equipped with a fully automatic camera.
Kidney sections of two schistosomal and two control cases
(cases number 8, 9, 18, 19 in Table 1) were stained by indirect
immunofluorescence using monoc/onal antischistosomal CAA
4
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Fig. 1. A. A case of membranoproliferative glomerulonephritis in a patient with end—stage renal failure and active schistosomiasis (HX and E
)< 345), B. Granular mesangial and capillary wall deposits of IgG in the same case of membranoproliferative glomerulonephritis (FITC labelled
anti-human IgG x 345). C. Granular deposits of CAA which are more mesangial than capillary basement membrane in a case of membranoprolifera-
tive glomerulonephritis (FITC labelled anti-schistosomal CAA X 345).
IgG3, using a working dilution '/2ooo, and antimouse IgG FITC
conjua gate diluted 'ho. This monoclonal antibody is a mouse
IgG3 isotype produced by fusion of spleen cells of an schisto-
soma—mansoni—infected Swiss mouse with SP (BALB/C)
myeloma cells. The antibody recognizes a repeating determi-
nant of CAA and therefore precepitates CAA in immunoelec-
trophoresis.
Rheumatoid factor
A search for rheumatoid factor in the serum of the patients
and the control cases was carried out. In addition, the frozen
kidney sections were examined with normal serum containing
IgG.
Results
Table I shows the clinical and the laboratory data of the cases
studied. Seventeen cases with active schistosoma—mansoni
infestation were examined; 14 were male and three were female
and their ages ranged between 18 and 42 years old. Eleven cases
presented with end—stage renal failure and were on chronic
hemodialysis therapy when biopsied, while six cases presented
with nephrotic syndrome. Three out of the six nephrotic pa-
tients were found to have moderate impairment of their kidney
function, with serum creatinine ranging between 3 to 5 mg/dl,
and two of these cases progressed to end—stage renal failure
within eight to 12 months.
Light microscopic examination of the renal biopsies of the
schistosomal cases showed mesangiocapillary glomerulonephri-
tis in nine cases (Fig. 1A), membranous glomerulonephritis in
four cases (Fig. 2A), focal segmental glomerulonephritis in two
cases, no change in one case and sclerosing glomerulonephritis
in one case. Immunofluorescent microscopic examination of
frozen sections showed IgG deposits in 13 cases and 1gM in 10,
and complement component (C3, Cl q) deposits were found in
eight cases. The deposits were granular in the capillary loops in
the membranous cases (Fig. 2B), in the mesangium and the
capillary loops in the membranoproliferative cases (Fig. 1B),
and in the sclerosed areas in cases with focal segmental
!LJ"'tt '.its•.'x.
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Fig. 2. A. A case of membranous glomerulonephritis in a patient with end—stage rena/failure and active schistosoma mansoni infestation (PAS
x 345). B. Granular deposits of IgG along the capillary basement membrane in the same case of membranous glomerulonephritis (FITC labelled
anti-human IgG X 345). C. Granular deposits of CAA along the capillary basement membrane in the case of membranous glomerulonephritis (FITC
labelled anti-schistosomal CAA x 345).
glomeruloscierosis. In the case with no changes, light micros-
copy showed finely granular deposits along the capillary walls.
Six non-schistosomal cases and a normal kidney tissue
served as controls. Four of these patients had end—stage renal
failure and were on chronic hemodialysis therapy when
biopsied, the other two patients had nephrotic syndrome and
normal kidney functions.
Light microscopic examination of these cases showed
membranoproliferative glomerulonephritis in three, membrane-
ous glomerulonephritis in two and focal segmental glomerulo-
sclerosis in one case. Immunofluorescent microscopic exami-
nation showed IgG, 1gM and IgA deposits. The normal kidney
tissue was found to be negative.
A search for rheumatoid factor was negative in patient sera,
and treatment of the slides with normal serum containing IgG
neither gave a positive fluorescent reaction nor blocked the
positivity to FITC labeled antihuman immunoglobulins.
Determination of protein content in the eluates showed a
mean value of 0.857 0.270 mg/mi in the schistosomal group
and 0.670 0.190 mg/mi in the control group. Examination of
the eluate by gel electrophoresis showed this protein to be
mainly of a gamma globulin nature; immunoelectrophoresis
showed IgG, 1gM and only traces of albumin.
ELISA examination of the tissue eluates against the adult
worm antigen (AWA) was positive among twelve out of the
seventeen schistosomal cases. Negative results were obtained
in all the control cases as well as the normal kidney tissue.
Figure 1 shows that the mean OD for ELISA positive
schistosomal cases was 0.56 0.20, while for the ELISA
negative cases the OD was 0.18 0.03 and for the control cases
was 0.18 0.01. Furthermore, prior treatment of tissue eluates
with schistosomal antigen resulted in inhibition of the ELISA
positive reaction by a mean value of 73.3 9.49%.
When stained by anti-CAA/FITC, all the ELISA positive
cases showed deposits of CAA which were granular in charac-
ter and distributed in the mesangeal and capillary wall (Fig. 1C,
2C). The ELISA negative cases, as well as the control cases and
the normal kidney tissue, were found to be negative for CAA
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deposits. Furthermore, similar results were obtained when
frozen sections of two schistosomal and two control cases were
stained by the monoclonal antischistosomal CAA IgG3.
Discussion
Most of the schistosomal nephropathy cases have been
reported to occur in association with schistosoma mansoni.
This has been explained be the presence of porto-systemic
collaterals in schistosoma mansoni infection. This will permit
the diversion of the immune complexes away from the liver and
its kupifer cells. Thus the complexes will reach the kidney and
other organs by the systemic circulation [4, 6, 91. Nevertheless,
Greenham and Cameron [5] have reported two cases of ne-
phrotic syndrome of membranoproliferative glomerulonephritis
associated with schistosoma hematobium infection.
In the early reports of schistosomal nephropathy, the
specifity of deposited immune complex to schistosomiasis was
not tested. A mere association between a non-specific glomer-
ulonephritis and bilharzial could not be denied. However, more
recently trials to document the bilharzial specific nature of the
immune complexes deposited in the glomeruli of cases with
glomerulonephritis were carried out. This was achieved by
examination of tissue eluates of kidney biopsies of infected
human [8—14] and animals [6, 8, 9, 15]. The eluates were tested
against adult worm antigen using ELISA [15] or immunoelec-
trophoresis [8, 91. Sumi et al [11] and Pamela and Edilson [12]
used the eluates for indirect immunofluorescent staining of a
sectioned adult worm and were able to show a reaction with the
gut and tegmentum of the worms.
Detection of schistosomal specific antibodies in the eluate of
kidney biopsy is not a sufficient proof for the schistosomal
specificity of the deposited immune complex, as this could be a
serum contamination, or they could be immunoglobulins which
are not included in the immune complexes causing the glomer-
ular pathology. Hoshino—shimizu et al [14], examined five
biopsies and seven necropsy specimens from schistosoma
mansoni patients and detected the presence of schistosoma
antigen in two cases; both had proliferative glomerulonephritis
and slight proteinuria.
Circulating anodic antigen (CAA), which is a schistosomal
specific antigen, had been demonstrated to be deposited in the
glomeruli of the experimental animals. Kelsoe and Weller [15]
and Van Mark, Deelder and Gigase [16] were able to detect
CAA in the kidney biopsies of infected hamsters and mice.
Similarly, our schistosomal and control cases had been
subjected to tissue elution. The eluates were found to have high
concentrations of protein. Part of this protein is possibly of
tissue origin, but there was no blood contamination since
immunoelectrophoresis showed IgG, 1gM and only traces of
albumin. Screening of our material by ELISA showed positive
reactions against AWA in 12 out of the 17 selected cases. In
addition, this reaction was inhibitable by prior treatment of the
eluate with schistosomal antigen; this signifies the schistosomal
specifity of the eluted antibodies. As these antibodies were
detected in six patients with nephrotic syndrome, three of them
had normal kidney functions and the other three had impaired
kidney function. In addition it had been observed in other six
patients with end—stage renal disease. This suggests that these
antibodies (anti-CAA) may have a role in the pathogenesis of
this type of glomerulonephritis. Furthermore, staining the bi-
opsy specimens with fluorescent conjugated anti-CAA and the
monoclonal antischistosomal CAA IgG3 showed deposits in the
glomeruli of the ELISA positive cases which were granular in
character and mesangeal and capillary wall in distribution. In
addition, a search for rheumatoid factor was negative in these
cases excluding the presence of a non-specific IgG or 1gM
antiglobulins.
Absence of anti-CAA in renal glomeruli of five out of 17
schistosomal cases could be explained either by the
schistosomal infestation being a mere coincidental finding with
other disease processes causing the renal pathology, such as an
idiopathic type of glomerulonephritis, or that the CAA and
anti-CAA are deposited in the renal glomeruli, but in concen-
trations below the limits of the sensitivity of the methods we
used (and probably could be detected if more sensitive tech-
niques were used, such as immunoelectron microscopy using
the colloid gold—labelling technique).
In our schistosomal cases it was observed that the histo-
pathologic nature of their kidney lesions were variable despite
the similarity in the immune reactants detected in their kidney
tissues. We have no explanation for this. This needs further
investigation in which the effect of deposition of other
schistosomal antigens, such as circulating cathodic antigen as
well as the antigen load and the duration of exposure to this
antigen, is to be studied. These and possibly other variables
could be responsible for the variability in the histopathologic
natures of the glomerular lesions in patients with active
schistosoma mansoni infestation.
Since evidence was provided that the immune complex
deposits in the glomeruli were schistosome specific, we con-
cluded that schistosomal nephropathy does exist in the clinical
setting. As seven out of eleven cases with end—stage renal
failure were found to have schistosomal specific nephropathy
and two cases with nephrotic syndrome progressed to
end—stage renal failure, we concluded that schistosomal specific
nephropathy can progress to end—stage renal failure. In addi-
tion, our data indicate that CAA is a major responsible antigen.
Nevertheless the implication of other antigens requires further
study. These data support the hypothesis that renal injury in
schistosomiasis is mediated through an immune complex dis-
ease. Circulating antigen—antibody complexes are deposited in
the glomeruli and complexing occurs in situ within the glomer-
ular capillary wall, resulting in glomerular injury. Another
possibility is that the CAA activity in kidney represents anti-
idiotypic antibodies versus anti-CAA and not the CAA antigen.
Schistosomal specific nephropathy in patients with end—stage
renal disease demonstrates the need for studies about the
incidence of the disease, its epidemiology, natural history, and
response to treatment in its early phases, particularly in coun-
tries in which the infestation with schistosomiasis is endemic.
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